BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 12592062)

  • 1. Body composition modulates the effects of hormone replacement therapy on growth hormone and insulin-like growth factor-I levels in postmenopausal women.
    Figueroa A; Going SB; Milliken LA; Blew R; Sharp S; Lohman TG
    Gynecol Obstet Invest; 2002; 54(4):201-6. PubMed ID: 12592062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leptin in postmenopausal women: influence of hormone therapy, insulin, and fat distribution.
    Gower BA; Nagy TR; Goran MI; Smith A; Kent E
    J Clin Endocrinol Metab; 2000 May; 85(5):1770-5. PubMed ID: 10843150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormonal determinants of regional body composition in adolescent girls with anorexia nervosa and controls.
    Misra M; Miller KK; Almazan C; Worley M; Herzog DB; Klibanski A
    J Clin Endocrinol Metab; 2005 May; 90(5):2580-7. PubMed ID: 15713709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between hormone replacement therapy use with body fat distribution and insulin sensitivity in obese postmenopausal women.
    Sites CK; Brochu M; Tchernof A; Poehlman ET
    Metabolism; 2001 Jul; 50(7):835-40. PubMed ID: 11436191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of exercise training and hormone replacement therapy on lean and fat mass in postmenopausal women.
    Figueroa A; Going SB; Milliken LA; Blew RM; Sharp S; Teixeira PJ; Lohman TG
    J Gerontol A Biol Sci Med Sci; 2003 Mar; 58(3):266-70. PubMed ID: 12634293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fat distribution and insulin sensitivity in postmenopausal women: influence of hormone replacement.
    Munoz J; Derstine A; Gower BA
    Obes Res; 2002 Jun; 10(6):424-31. PubMed ID: 12055317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Sex Hormones, IGF-1, and IGFBP3 Exert a Sexually Dimorphic Effect on Lean Body Mass in Aging.
    Waters DL; Yau CL; Montoya GD; Baumgartner RN
    J Gerontol A Biol Sci Med Sci; 2003 Jul; 58(7):648-52. PubMed ID: 12865482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone replacement therapy affects body composition and leptin differently in obese and non-obese postmenopausal women.
    Kristensen K; Pedersen SB; Vestergaard P; Mosekilde L; Richelsen B
    J Endocrinol; 1999 Oct; 163(1):55-62. PubMed ID: 10495407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-dependent changes in body composition in postmenopausal Japanese women: relationship to growth hormone secretion as well as serum levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.
    Sugimoto T; Nakaoka D; Nasu M; Kanzawa M; Sugishita T; Chihara K
    Eur J Endocrinol; 1998 Jun; 138(6):633-9. PubMed ID: 9678529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone replacement therapy, insulin sensitivity, and abdominal obesity in postmenopausal women.
    Ryan AS; Nicklas BJ; Berman DM
    Diabetes Care; 2002 Jan; 25(1):127-33. PubMed ID: 11772913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interrelationships of spontaneous growth hormone axis activity, body fat, and serum lipids in healthy elderly women and men.
    O'Connor KG; Harman SM; Stevens TE; Jayme JJ; Bellantoni MF; Busby-Whitehead MJ; Christmas C; Münzer T; Tobin JD; Roy TA; Cottrell E; St Clair C; Pabst KM; Blackman MR
    Metabolism; 1999 Nov; 48(11):1424-31. PubMed ID: 10582552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased serum levels of growth hormone and insulin-like growth factor-I associated with simultaneous decrease of circulating insulin in postmenopausal women receiving hormone replacement therapy.
    Fonseca E; Ochoa R; Galván R; Hernández M; Mercado M; Zárate A
    Menopause; 1999; 6(1):56-60. PubMed ID: 10100181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor-I response to a single bolus of growth hormone is increased in obesity.
    Gleeson HK; Lissett CA; Shalet SM
    J Clin Endocrinol Metab; 2005 Feb; 90(2):1061-7. PubMed ID: 15522943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary data on the relationship between circulating levels of Sirtuin 4, anthropometric and metabolic parameters in obese subjects according to growth hormone/insulin-like growth factor-1 status.
    Savastano S; Di Somma C; Colao A; Barrea L; Orio F; Finelli C; Pasanisi F; Contaldo F; Tarantino G
    Growth Horm IGF Res; 2015 Feb; 25(1):28-33. PubMed ID: 25466907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relations between body composition, functional and hormonal parameters and quality of life in healthy postmenopausal women.
    Lebrun CE; van der Schouw YT; de Jong FH; Pols HA; Grobbee DE; Lamberts SW
    Maturitas; 2006 Aug; 55(1):82-92. PubMed ID: 16497451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone secretion and leptin in morbid obesity before and after biliopancreatic diversion: relationships with insulin and body composition.
    De Marinis L; Bianchi A; Mancini A; Gentilella R; Perrelli M; Giampietro A; Porcelli T; Tilaro L; Fusco A; Valle D; Tacchino RM
    J Clin Endocrinol Metab; 2004 Jan; 89(1):174-80. PubMed ID: 14715846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The route of estrogen replacement therapy confers divergent effects on substrate oxidation and body composition in postmenopausal women.
    O'Sullivan AJ; Crampton LJ; Freund J; Ho KK
    J Clin Invest; 1998 Sep; 102(5):1035-40. PubMed ID: 9727072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure.
    Svensson J; Lönn L; Jansson JO; Murphy G; Wyss D; Krupa D; Cerchio K; Polvino W; Gertz B; Boseaus I; Sjöström L; Bengtsson BA
    J Clin Endocrinol Metab; 1998 Feb; 83(2):362-9. PubMed ID: 9467542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of replacement estrogen on insulin-like growth factor-I in postmenopausal women: the Rancho Bernardo Study.
    Goodman-Gruen D; Barrett-Connor E
    J Clin Endocrinol Metab; 1996 Dec; 81(12):4268-71. PubMed ID: 8954026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of C-reactive protein are associated with obesity, weight gain, and hormone replacement therapy in healthy postmenopausal women.
    Barinas-Mitchell E; Cushman M; Meilahn EN; Tracy RP; Kuller LH
    Am J Epidemiol; 2001 Jun; 153(11):1094-101. PubMed ID: 11390329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.